BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2006

View Archived Issues

Pharmacokinetic and clinical studies of the insomnia treatment gaboxadol presented

Read More

Ceragenix enters agreement for formulation work of CSA-13 nasal ointment

Read More

Mayne Pharma acquires SuperGen's North American oncology products

Read More

Enrollment completed in follow-up study for Pollinex Quattro allergy vaccine

Read More

IND approval for Neocartilage clinical trials

Read More

Phase II SBIR grant for preclinical work on Panacea's stroke drug

Read More

QuatRx licenses 17-beta HSD-1 inhibitors from Solvay

Read More

Celera Genomics and Medarex collaborate on therapeutic antibodies in cancer

Read More

Otoprotective drug AM-111 shows benefit in acute sensorineural hearing loss

Read More

Riquent MAA accepted for review in Europe

Read More

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

Read More

Johnson & Johnson report on new candidates for excessive daytime sleepiness disorders

Read More

Daily dosing with PR-171 shown safe and effective in cancer animal models

Read More

Neurocrine and Pfizer terminate indiplon collaboration

Read More

CE Mark for Cypher Select PLUS

Read More

AV-650 cleared to begin U.S. clinical trials

Read More

Phase III studies of sarizotan fail to meet primary efficacy endpoint

Read More

Recordati inlicenses Infasurf for E.U.

Read More

Proof-of-concept study begins for pagoclone in premature ejaculation

Read More

Acapodene may lower cholesterol in men receiving androgen deprivation therapy

Read More

Molecular docking studies of bosutinib identify residues essential for stable binding

Read More

Inhibition of FAAH modulates sleep patterns by increasing brain endocannabinoids

Read More

Preclinical and preliminary clinical antidiabetic profiles of the novel, DPP-IV inhibitor GRC-8200

Read More

N-5984 pharmacokinetics, safety and efficacy in healthy subjects and obese, diabetic patients

Read More

Preclinical antidiabetic efficacy and pharmacokinetics of the DPP-IV inhibitor, SYR-322

Read More

Novartis seeks Japanese approval of Xolair

Read More

Lilly files for Japanese approval of pemetrexed for malignant pleural mesothelioma

Read More

Wyeth files NDAs for women's health therapies

Read More

Recent patents impart new anticancer agents

Read More

New gastric acid antisecretory agents emerge from Altana Pharma R&D

Read More

New agents for neurological disorders subject of recent patents

Read More

Cyclohexanehexol Abeta inhibitors from Transition Therapeutics improve cognition in vivo

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing